Can probiotics prevent or improve common cold and influenza?

Nutrition

Volumn 29, Issue 5, 2013, Pages 805-806

  Homayouni Rad, Aziz ^a   Torab, Reza ^b   Mortazavian, Amir Mohammad ^c   Mehrabany, Elnaz Vaghef ^a   Mehrabany, Leila Vaghef ^d  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

GANEDENBC30; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

B LYMPHOCYTE; BACILLUS COAGULANS; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM LONGUM; CELL PROLIFERATION; COMMON COLD; CYTOKINE PRODUCTION; DISEASE DURATION; DISEASE SEVERITY; DRUG MECHANISM; EDITORIAL; HUMAN; IMMUNOMODULATION; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; INFLUENZA; INFLUENZA A; LACTOBACILLUS GASSERI; LACTOBACILLUS PLANTARUM; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SUPPLEMENTATION;

ADULT; AGED; BACTERIA; COMMON COLD; HUMANS; INFANT; INFLUENZA, HUMAN; PROBIOTICS;

EID: 84876308698     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2012.10.009     Document Type: Editorial

References (20)

1. Heikkinen T., Järvinen A. The common cold. Lancet 2003, 361:51-59.
2. Vouloumanou E.K., Makris G.C., Karageorgopoulos D.E., Falagas M.E. Probiotics for the prevention of respiratory tract infections: A systematic review. Int J Antimicrob Agents 2009, 34:197.e1-197.e10.
3. Homayouni A. Letter to the editor. Food Chemistry 2009, 114:1073.
4. Ejtahed H.S., Mohtadi-Nia J., Homayouni-Rad A., Niafar M., Asghari-Jafarabadi M., Mofid V. Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition 2012, 28:539-543.
5. de Vrese M., Schrezenmeir J. Probiotics and non-intestinal infectious conditions. Br J Nutr 2002, 88:S59-S66.
6. Hatakka K., Saxelin M. Probiotics in intestinal and non-intestinal infectious diseases-Clinical evidence. Curr Pharm Des 2008, 14:1351-1367.
7. Rautava S., Salminen S., Isolauri E. Specific probiotics in reducing the risk of acute infections in infancy-A randomised, double-blind, placebo-controlled study. Br J Nutr 2009, 101:1722-1726.
8. Leyer G.L., Li S., Mubasher M.E., Reifer C., Ouwehand A.C. Probiotic effects on cold and influenza-like symptom incidence and duration in children. Pediatrics 2009, 124:e172-e179.
9. Kukkonen K., Savilahti E., Haahtela T., Juntunen-Backman K., Korpela R., Poussa T., et al. Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: Randomized, double-blind, placebo-controlled trial. Pediatrics 2008, 122:8-12.
10. Aubin J., Remigy M., Verseil L., Bourdet-Sicard R., Vaudaine S., van der Werf S., et al. A probiotic fermented dairy product improves immune response to influenza vaccination in the elderly. Proceedings of the Nutrition Society 2008, 67:205-220.
11. Boge T., Rémigy M., Vaudaine S., Tanguy J., Bourdet-Sicardc R., van der Werf S. A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials. Vaccine 2009, 27:5677-5684.
12. Bosch M., Méndez M., Pérez M., Farran M., Fuentes M.C., Cuñé J. Lactobacillus plantarum CECT7315 and CECT7316 stimulate immunoglobulin production after influenza vaccination in elderly. Nutr Hosp 2012, 27:504-509.
13. Davidson L.E., Fiorino A.M., Snydman D.R., Hibberd P.L. Lactobacillus GG as an immune adjuvant for live-attenuated influenza vaccine in healthy adults: A randomized double-blind placebo-controlled trial. Eur J Clin Nut 2011, 65:501-507.
14. Namba K., Hatano M., Yaeshima T., Takase M., Suzuki K. Effects of bifidobacterium longum BB536 administration on influenza infection, influenza vaccine antibody titer, and cell-mediated immunity in the elderly. Biosci Biotechnol Biochem 2010, 74:939-945.
15. de Vrese M., Winkler P., Rautenberg P., Harder T., Noah C., Laue C., et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: A double blind, randomized, controlled trial. Clin Nutr 2005, 24:481-491.
16. Baron M. A patented strain of Bacillus coagulans increased immune response to viral challenge. Postgrad Med 2009, 121:114-118.
17. Berggren A., Lazou Ahrén I., Larsson N., önning G. Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. Eur J Nutr 2011, 50:203-210.
18. Delcenserie V., Martel D., Lamoureux M., Amiot J., Boutin Y., Roy D. Immunomodulatory effects of probiotics in the intestinal tract. Curr Issues Mol Biol 2008, 10:37-54.
19. Homayouni Rad A., Vaghef Mehrabany E., Alipoor B., Vaghef Mehrabany L., Javadi M. Do probiotics act more efficiently in foods than in supplements?. Nutrition 2012, 28:733-736.
20. Homayouni Rad A., Akbarzadeh F., Vaghef Mehrabany E. Which are more important: Prebiotics or probiotics?. Nutrition 2012, 28:1196-1197.